医药品无菌实验的全球市场:现状分析与预测(2022年～2028年)

全球医药品无菌实验的市场规模在预测期间内预计将以以约9％的显着速度增长。推动市场增长的主要因素包括人口增长对有效药物的需求持续增加、疾病流行率上升等。

本报告提供全球医药品无菌测试市场调查，提供市场概要，按市场规模和预测，趋势，促进因素·阻碍因素，样品·各类型·各地区的分析，及企业简介等资讯。

目录

第1章 市场简介

• 市场定义
• 主要目的
• 相关利益者
• 限制

第2章 调查手法或前提条件

• 医药品无菌测试市场的调查流程
• 医药品无菌测试市场的调查手法
• 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19影响

第6章 医药品无菌实验市场收益，2020年～2028年

第7章 市场洞察:各样品

• 无菌药
• 医疗设备
• 生技药品·治疗药

第8章 市场洞察:各类型

• 设备
• 套件·试剂
• 服务

第9章 市场洞察:各地区

• 北美
  • 美国
  • 加拿大
  • 其他的北美
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他的欧洲
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他的亚太地区
• 其他地区

第10章 医药品无菌实验的市场动态

• 推动市场要素
• 阻碍市场要素
• 影响分析

第11章 医药品无菌实验市场机会

第12章 医药品无菌测试市场趋势

第13章 需求面和供给面的分析

• 需求面分析
• 供给面的分析

第14章 价值链分析

第15章 竞争模式

• 竞争情形
  • 波特的五力分析

第16章 企业简介

• Pacific Biolabs
• STRERIS Corporation
• Boston Analytical
• Gibraltar Laboratories
• Sartorius AG
• SolviasAG
• SGS AG
• Toxikon Inc.
• Merck KGaA
• Charles River Laboratories International Inc.

第17章 免责声明

The global pharmaceutical sterility testing market is expected to grow at a significant rate of around 9% during the forecast period. Sterilization may be defined as the statistically complete destruction of all microorganisms including the most resistant bacteria and spores. The continuously rising demand for effective medicines due to the increasing population and rising disease prevalence among them are important factors for the growth of pharmaceutical sterility testing. For instance, in 2019, 37.3 million Americans, or 11.3% of the population, had diabetes. Furthermore, strict government regulation on microbial control and good manufacturing process also contributes to the market growth of the pharmaceutical sterility testing industry.

Pacific Biolabs, STRERIS Corporation, Boston Analytical, Gibraltar Laboratories, Sartorius AG, SolviasAG, SGS AG, Toxikon inc., Merck KGaA, and Charles River Laboratories International Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst sample, sterile drugs category to witness higher CAGR during the forecast period"

Based on the sample, the market has been categorized into sterile drugs, medical devices, and biologics & therapeutics. The sterile drugs category is expected to witness a higher CAGR during the forecast period. This is mainly due to these drugs directly coming in the contact with the internal body organs and the aftermath of the contaminated drugs can be severe. Furthermore, the rising demand for injectable drugs due to their high absorption in the body is also attributed to the segmental growth of sterile drugs.

"Amongst type, the services to hold a significant share in the market in 2020"

Based on the type, the market has been categorized into instruments, kits & reagents, and services. Among them, the service segment is expected to have significant growth in the market. The companies are also providing new services in the sterility testing market catalyzing the segmental growth in the market. For instance, in October 2019, Alcami Corporation launched a rapid sterility offering, a service that leverages cutting-edge microbiological testing technology to deliver significantly faster-testing results to clients.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the pharmaceutical sterility testing industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. In 2020, North America held a significant share of the global pharmaceutical sterility testing market. This is mainly attributed to the high investment in the healthcare and pharmaceutical sectors coupled with the strict guidelines on the good manufacturing process. For instance, $192 million for coronavirus research and medical countermeasures from the government's Plan to Mobilize Science

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

• The report presents a quick review of overall industry performance at one glance.

• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

• The study comprehensively covers the market across different segments.

• Deep dive regional level analysis of the industry.

Customization Options:

The global pharmaceutical sterility testing market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Pharmaceutical Sterility Testing Market
• 2.2. Research Methodology of the Pharmaceutical Sterility Testing Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE PHARMACEUTICAL STERILITY TESTING MARKET

6 PHARMACEUTICAL STERILITY TESTING MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY SAMPLE

• 7.1. Sterile Drugs
• 7.2. Medical Devices
• 7.3. Biologics & Therapeutics

8 MARKET INSIGHTS BY TYPE

• 8.1. Instruments
• 8.2. Kits & Reagents
• 8.3. Services

9 MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1. The United States
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. The United Kingdom
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of Asia-Pacific
• 9.4. Rest of World

10 PHARMACEUTICAL STERILITY TESTING MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 PHARMACEUTICAL STERILITY TESTING MARKET OPPORTUNITIES

12 PHARMACEUTICAL STERILITY TESTING MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

• 15.1. Competitive Landscape
  • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

• 16.1. Pacific Biolabs
• 16.2. STRERIS Corporation
• 16.3. Boston Analytical
• 16.4. Gibraltar Laboratories
• 16.5. Sartorius AG
• 16.6. SolviasAG
• 16.7. SGS AG
• 16.8. Toxikon Inc.
• 16.9. Merck KGaA
• 16.10. Charles River Laboratories International Inc.

17 DISCLAIMER